Larvol Delta - 858-Therapeuticsannounced-that-the-US-Food-and-Drug-Administration-FDA-has-granted-Fast-Track-designation-to-ETX19477-the-companys-internally-discovered-PARG-inhibitor

ETX-19477 - 858 Therap

https://www.businesswire.com/news/home/20260108319598/en/858-Therapeutics-Announces-FDA-Fast-Track-Designation-for-PARG-Inhibitor-ETX-19477-for-the-Treatment-of-Patients-with-BRCA-Mutated-Platinum-Resistant-Ovarian-Cancer

Jan 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next